Aptose Biosciences Inc (APTO)
1.21
+0.02
(+1.68%)
USD |
NASDAQ |
May 03, 16:00
1.21
0.00 (0.00%)
After-Hours: 16:14
Aptose Biosciences Price: 1.21 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 1.19 | 1.212 | 1.19 | 1.19 | 32032.00 |
May 01, 2024 | 1.23 | 1.23 | 1.19 | 1.21 | 35738.00 |
Apr 30, 2024 | 1.20 | 1.24 | 1.20 | 1.20 | 38504.00 |
Apr 29, 2024 | 1.24 | 1.25 | 1.18 | 1.23 | 52126.00 |
Apr 26, 2024 | 1.21 | 1.27 | 1.16 | 1.22 | 104878.0 |
Apr 25, 2024 | 1.19 | 1.235 | 1.15 | 1.16 | 47108.00 |
Apr 24, 2024 | 1.26 | 1.26 | 1.20 | 1.22 | 56240.00 |
Apr 23, 2024 | 1.23 | 1.278 | 1.20 | 1.23 | 73125.00 |
Apr 22, 2024 | 1.23 | 1.260 | 1.210 | 1.23 | 12898.00 |
Apr 19, 2024 | 1.24 | 1.285 | 1.23 | 1.231 | 36438.00 |
Apr 18, 2024 | 1.25 | 1.29 | 1.25 | 1.27 | 34780.00 |
Apr 17, 2024 | 1.27 | 1.34 | 1.258 | 1.26 | 31324.00 |
Apr 16, 2024 | 1.29 | 1.32 | 1.20 | 1.27 | 45647.00 |
Apr 15, 2024 | 1.39 | 1.40 | 1.29 | 1.30 | 65087.00 |
Apr 12, 2024 | 1.39 | 1.440 | 1.34 | 1.36 | 35185.00 |
Apr 11, 2024 | 1.40 | 1.43 | 1.37 | 1.38 | 51284.00 |
Apr 10, 2024 | 1.39 | 1.476 | 1.38 | 1.38 | 54000.00 |
Apr 09, 2024 | 1.48 | 1.49 | 1.40 | 1.41 | 179377.0 |
Apr 08, 2024 | 1.45 | 1.52 | 1.38 | 1.47 | 113186.0 |
Apr 05, 2024 | 1.41 | 1.470 | 1.38 | 1.38 | 56092.00 |
Apr 04, 2024 | 1.47 | 1.56 | 1.39 | 1.43 | 134594.0 |
Apr 03, 2024 | 1.57 | 1.58 | 1.44 | 1.44 | 113290.0 |
Apr 02, 2024 | 1.65 | 1.67 | 1.51 | 1.58 | 102707.0 |
Apr 01, 2024 | 1.72 | 1.720 | 1.53 | 1.60 | 122551.0 |
Mar 28, 2024 | 1.50 | 1.70 | 1.50 | 1.66 | 137093.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.16
Minimum
Apr 25 2024
135.00
Maximum
Feb 20 2020
38.13
Average
30.38
Median
Price Benchmarks
Acasti Pharma Inc | 2.875 |
Aurinia Pharmaceuticals Inc | 5.095 |
Edesa Biotech Inc | 4.53 |
Lexaria Bioscience Corp | 3.11 |
Xenon Pharmaceuticals Inc | 43.75 |
Price Related Metrics
Earnings Yield | -638.0% |
Market Cap | 19.02M |